Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Kolchinsky Peter sold 678,226 Werewolf Therapeutics, Inc. shares (Form 4)
Traded Jun 9 to Jun 11, 2026 · Filed Jun 11, 2026
From Jun 9 to Jun 11, 2026, Kolchinsky Peter (10% owner) sold 678,226 Werewolf Therapeutics, Inc. shares at an average US$0.37 for US$254K, leaving 361,229 shares. Filed Jun 11, 2026 (Form 4).
- Sold
- 678,226 shares
- Price
- US$0.37 average (US$0.37 to US$0.38)
- Value
- US$254K
- Holding after
- 361,229 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Sale | 345,235 | US$0.37 | 5,364,623 | Indirect |
| Jun 9, 2026 | Common Stock | Sale | 24,565 | US$0.37 | 381,717 | Indirect |
| Jun 10, 2026 | Common Stock | Sale | 42,872 | US$0.37 | 5,321,751 | Indirect |
| Jun 10, 2026 | Common Stock | Sale | 3,051 | US$0.37 | 378,666 | Indirect |
| Jun 11, 2026 | Common Stock | Sale | 245,066 | US$0.38 | 5,076,685 | Indirect |
| Jun 11, 2026 | Common Stock | Sale | 17,437 | US$0.38 | 361,229 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Kolchinsky Peter
- Werewolf Therapeutics, Inc. shareholders
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026